Edtech platform BrightChamps has acquired Edjust, a K12 education platform, in a cash and stock transaction. Edjust uses ...

Bespak are a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and ...

Phillips Medisize expands its inhalation drug delivery capabilities: Hudson, Wisconsin Thursday, January 9, 2025, 11:00 Hrs [IST] Molex, a parent to Phillips Medisize announced th ...

This inhaler requires hand pressure to test the patient’s hand-mouth coordination and can easily compromise efficacy due to improper handling. The dry powder inhaler (DPI) of FF/UMEC/VI is relatively ...

Expands Phillips Medisize’s inhalation drug delivery capabilities.

and dry powder inhaler (DPI) devices. DPI device availability is limited to "controller" medications, while pMDI devices and nebulizers provide complete symptomatic coverage. Multiple-dose DPIs ...

Here’s what they did and what they found. Good asthma care and appropriate inhaler prescribing are key components of reducing the environmental impact of general practice. Metered dose inhalers (MDI) ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

Wixela Inhub is also a DPI. Soft mist inhalers (SMIs) are propellant-free devices that are slightly larger than MDIs. The devices release a low-velocity mist that can be slowly inhaled over a longer ...

Hannah Garden-Monheit, the director of the FTC's Office of Policy Planning, said in a statement that the decision was "important not only for lowering asthma inhaler costs, it also sets the stage ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...